High efficacy and low toxicity of weekly docetaxel given as first-line treatment for metastatic breast cancer.
Stemmler J, Mair W, Stauch M, Papke J, Deutsch G, Abenhardt W, Dorn B, Kentenich C, Malekmohammadi M, Jackisch C, Leinung S, Brudler O, Vehling-Kaiser U, Stamp J, Heinemann V.
Stemmler J, et al. Among authors: heinemann v.
Oncology. 2005;68(1):71-8. doi: 10.1159/000084823. Epub 2005 Mar 12.
Oncology. 2005.
PMID: 15809523
Free article.
Clinical Trial.